Darshin Patel discusses the first-of-its-kind Sapien M3 TMVR system's design, development and lessons for other medical ...

The TEER procedure involves placing a device via a ventricular catheter to connect the edges of the mitral valve, significantly reducing or eliminating leakage. Recovery involves up to six weeks of ...

The TEER procedure involves placing a device via a ventricular catheter to connect the edges of the mitral valve, significantly reducing or eliminating leakage. Recovery involves up to six weeks ...

Edwards Lifesciences’ EW first-quarter 2025 performance was backed by its most comprehensive structural heart disease portfolio. In the TTMT (Transcatheter Mitral and Tricuspid Therapies) segment, the ...

This revolutionary transcatheter valve therapy is built on the proven ... M3 that this is a product that's geared toward the TEER and mitral surgery unsuitable patients, so for patients who ...

mitral regurgitation who are deemed unsuitable for surgery or transcatheter edge-to-edge (TEER) therapy. Edwards Lifesciences designed the system’s catheter-delivered nitinol dock to anchor the Sapien ...

2 During the TEER procedure, a 2- to 3-inch incision is made in the chest wall of a dog under general anesthesia. 3 Using a ventricular catheter, a device to connect the edges of the mitral valve is ...

Mitral annular disjunction in mitral valve prolapse with mitral regurgitation was tied to a threefold increase in long-term ...

An 11-year-old boy recently became the first person in the world to have an artificial heart valve replaced with a living ...

Malnutrition among patients with symptomatic tricuspid regurgitation receiving T-TEER is independently associated with increased mortality.

The global transcatheter mitral valve market is on a strong growth trajectory, with projections estimating a market valuation of USD 1.6 billion by the end of 2024 and an impressive compound annual ...